Shared Resource: Biosample Repository Facility
共享资源:生物样本储存库设施
基本信息
- 批准号:9754605
- 负责人:
- 金额:$ 15.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAdvisory CommitteesBasic ScienceBioinformaticsBiologicalBiological MarkersBiological ModelsBiometryBloodBlood CellsBlood DonationsBlood specimenCancer BiologyCancer CenterCancer Center Support GrantCancer ControlCell Culture TechniquesCell SeparationClinicalClinical DataCollaborationsCollectionComprehensive Cancer CenterComputer AssistedConsentCustomDetectionDevelopmentDevelopment PlansDiagnosticDoctor of PhilosophyDrug or chemical Tissue DistributionEnzyme-Linked Immunosorbent AssayEpigenetic ProcessEthicsFamily Cancer HistoryFamily memberFarming environmentFox Chase Cancer CenterFoxesFreezingFundingFutureGenomicsGoalsHealthHealth systemHistopathology FacilityHospital PersonnelHumanImmunoperoxidase TechnicsIndividualInformed ConsentInstitutional Review BoardsInterleukin-6InternationalInterventionLaboratory AnimalsLinkMalignant - descriptorMalignant NeoplasmsMedical OncologistMolecularNormal tissue morphologyParticipantPathologicPathologistPathologyPatient Self-ReportPatientsPeer ReviewPopulation StudyProceduresProcessRecording of previous eventsResearchResearch PersonnelResearch SupportResource SharingResourcesSamplingServicesSpecimenStainsSupervisionSurgeonSurgical PathologyTherapeuticTissue BanksTissue MicroarrayTissue SampleTissuesTrainingTransgenic Mouse FacilityTranslational ResearchUniversitiesUniversity HospitalsUrineWorkanimal facilityautomated image analysiscancer preventionclinical databasehigh throughput screeningimaging facilitiesimaging systemlifestyle factorsliquid crystal polymermedical schoolsmembermolecular modelingpatient orientedperipheral bloodprogramsquantitative imagingrepositoryresearch studyvolunteer
项目摘要
MODEL SYSTEMS SHARED RESOURCE: BIOSAMPLE REPOSITORY FACILITY (BRF)
PROJECT SUMMARY/ABSTRACT
Fox Chase Cancer Center (FCCC) established biospecimen banking activities in 1987 to coordinate the ethical
collection, storage, annotation and distribution of tissue and peripheral blood samples to support translational
research. This centralized shared resource operates under the supervision of Denise Connolly, PhD (MT) and
is advised by an inter-programmatic Facility Advisory Committee (FAC). To enhance BRF services, the Center
invested $369,770 for a PE Vectra Multispectral Quantitative Imaging System and a MesoScale Discovery
chemiluminescent ELISA platform. The Biosample Repository Facility (BRF) has three major functions: 1) to
identify participants, obtain informed consent, collect tissue, blood and/or urine specimens and obtain
information on personal and family histories of cancer, clinical intervention and lifestyle factors for use in
research; 2) to process and store human biospecimens obtained through investigator-initiated studies; and 3)
to provide tissue-related analysis services including custom tissue microarray (TMA) construction, standard
immunoperoxidase and fluorescent immunohistochemical detection and analysis of biomarker expression.
Working in collaboration with pathologists, medical oncologists, surgeons and other hospital personnel,
specifically trained BRF staff obtains subject informed consent, collects samples and assembles
comprehensive clinical, pathological and personal/demographic information about each donor and the
corresponding samples. As part of this banking process, the BRF staff provides: 1) diagnostic pathology
support; 2) a comprehensive informed consent process for the appropriate collection of tissue, blood and other
biospecimens for research; 3) a specialized biospecimen bank devoted to the collection and distribution of de-
identified specimens to support research; 4) custom TMA construction; 5) immunohistochemical staining; 6)
computer assisted tissue analysis services; and 7) extensive supporting data from the clinical record and self-
reported health history of each participant. All specimens collected by and housed in the BRF are linked to
comprehensive clinical databases supported by the Population Studies Facility (PSF). The BRF currently
houses over 16,500 fresh-frozen tissue samples, over 47,000 blood samples, and has access to >100,000
surgical pathology cases. The annual accruals for new tissue and blood specimens are approximately 1,500
and 3,000, respectively. In 2014, the BRF served 31 FCCC investigators (24 peer-review funded) across all
five Research Programs. Ninety (90%) percent of the BRF's 2014 use (by primary service line) was by
peer-review funded Cancer Center members. Future plans involve the Center's commitment to construct a
dedicated freezer farm that will provide sample storage capacity for the next ten years.
模型系统共享资源:生物样本储存工厂(BRF)
项目总结/摘要
福克斯蔡斯癌症中心(FCCC)于1987年建立了生物标本库活动,以协调伦理学
组织和外周血样本的采集、储存、注释和分发,以支持翻译
research.这种集中的共享资源在Denise Connolly博士(MT)的监督下运作,
由方案间融资机制咨询委员会(FAC)提供咨询。为了加强BRF服务,中心
投资369,770美元用于PE Vectra多光谱定量成像系统和MesoScale Discovery
荧光ELISA平台。生物样品储存设施(BRF)有三个主要功能:1)
确定参与者,获得知情同意,采集组织、血液和/或尿液样本,并获得
癌症的个人和家族史、临床干预和生活方式因素的信息,
研究; 2)处理和储存通过制药商发起的研究获得的人类生物标本;以及3)
提供组织相关分析服务,包括定制组织微阵列(TMA)构建、标准
免疫过氧化物酶和荧光免疫组织化学检测和生物标志物表达分析。
与病理学家、医学肿瘤学家、外科医生和其他医院工作人员合作,
经过专门培训的BRF工作人员获得受试者知情同意书,采集样本并组装
关于每个捐赠者和捐赠者的全面的临床、病理和个人/人口统计信息。
相应的样品。作为这一银行业务流程的一部分,BRF工作人员提供:1)诊断病理学
支持; 2)一个全面的知情同意过程,以适当收集组织,血液和其他
研究用生物标本; 3)专门的生物标本库,致力于收集和分发非生物标本,
鉴定标本以支持研究; 4)定制TMA构建; 5)免疫组织化学染色; 6)
计算机辅助组织分析服务;和7)来自临床记录和自我的广泛支持数据,
报告每位参与者的健康史。所有由BRF采集和保存的标本均与
由人口研究设施(PSF)支持的综合临床数据库。BRF目前
拥有超过16,500份新鲜冷冻组织样本,超过47,000份血液样本,并可获得> 100,000份
外科病理学病例。新组织和血液标本的年度应计费用约为1,500
分别为3,000。2014年,BRF为31名FCCC调查员(24名同行评审资助)提供了服务。
五个研究项目。BRF 2014年使用量的90%(按主要服务项目)是由
同行评审资助的癌症中心成员。未来的计划涉及该中心的承诺,建设一个
专门的冷冻场,将提供未来十年的样品储存能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DENISE C CONNOLLY其他文献
DENISE C CONNOLLY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DENISE C CONNOLLY', 18)}}的其他基金
Pilot Research Project: Evaluating Black and African American Breast Cancer Populations for Therapeutic Targeting of Aberrant p53, MDM2, MDMX, and PARP signaling
试点研究项目:评估黑人和非裔美国人乳腺癌人群的异常 p53、MDM2、MDMX 和 PARP 信号传导靶向治疗
- 批准号:
10757261 - 财政年份:2018
- 资助金额:
$ 15.94万 - 项目类别:
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
HEF1 在卵巢癌发生、进展和转移中的作用
- 批准号:
8238368 - 财政年份:2009
- 资助金额:
$ 15.94万 - 项目类别:
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
HEF1 在卵巢癌发生、进展和转移中的作用
- 批准号:
7730607 - 财政年份:2009
- 资助金额:
$ 15.94万 - 项目类别:
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
HEF1 在卵巢癌发生、进展和转移中的作用
- 批准号:
8052931 - 财政年份:2009
- 资助金额:
$ 15.94万 - 项目类别:
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
HEF1 在卵巢癌发生、进展和转移中的作用
- 批准号:
8460153 - 财政年份:2009
- 资助金额:
$ 15.94万 - 项目类别:
Shared Resource: Biosample Repository Facility
共享资源:生物样本储存库设施
- 批准号:
10427539 - 财政年份:1997
- 资助金额:
$ 15.94万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 15.94万 - 项目类别:
Standard Grant